Early-stage investment platform Venture Catalysts (VC) said on Tuesday that it has taken an exit from health startup Pee Safe, recording 9.6x return on invested capital. The firm saw an extended internal rate of return (XIRR) of 30.53% for its fund and limited partners. The exit followed Pee Safe’s recent $32 million funding round led by private equity firm, OrbiMed.